The Alexander von Humboldt Foundation, established by the German government in 1953, promotes academic cooperation and exchange among scientists and scholars from Germany and abroad. The foundation has bestowed this year's award to Professor Suck-Joo Na of KAIST's Mechanical Engineering Department in recognition of his lifetime achievements.
Professor Na's main interests are in the fields of arc and laser welding, computational fluid dynamics simulation, residual stress and distortion, and design of welded structures. He has received numerous honors and awards including the Research Fellowship Award from the Alexander von Humboldt Foundation (1989), the Excellent Research Paper Award from the Korean Welding and Joining Society (1993), the Charles H. Jennings Memorial Award from the American Welding Society (2003), and the Yoshiaki Arata Award from the International Institute of Welding (2014).
The Humboldt Research Award is granted annually to up to 100 academics whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future.
The award winners also receive a research grant of 60,000 Euros and are invited to work up to one year with colleagues at research institutions in Germany. Nominations for the award are made only by established academic institutions in Germany.
Professor Na will collaborate with a research team led by Professor Michael Rethmeier at the Berlin-based Federal Institute for Materials Research and Testing (BAM) to conduct research in laser welding and selective laser melting, as well as the mathematical analysis of these manufacturing processes from July 2017 to the end of February 2018.

<(Top row, from left) Professor Kang Taek Lee, Ph.D candidate Yejin Kang, Dr. Dongyeon Kim, (Bottom row, from left) M.S candidate Mincheol Lee, Ph.D candidate Seeun Oh, Ph.D candidate Seungsoo Jang, Ph.D candidate Hyeonggeun Kim> As power demand surges in the AI era, the “protonic ceramic electrochemical cell (PCEC),” which can simultaneously produce electricity and hydrogen, is gaining attention as a next-generation energy technology. However, this cell has faced the techni
2025-12-05<Groundbreaking Ceremony Shovel Scene for the KAIST National Quantum Fab Research Building> KAIST announced on December 3rd that it held the opening ceremony for the National Quantum Fab Research Institute and the groundbreaking ceremony for the Quantum Fab Research Building at the KAIST main campus in Daejeon, officially commencing the construction of the nation's core infrastructure to enhance South Korea's quantum technology competitiveness. The event began with a progress report an
2025-12-04<(From left in the front row) Professor Nam-Soon Choi, Professor Dong-Hwa Seo, (back row, from left) Ph.D candidate Gihoon Lee, Ph.D candidate Seung Hee Han, Ph.D candidate Jae-Seung Kim, (top) M.S candidate Junyoung Kim> High-nickel batteries, which are high-energy lithium-ion batteries primarily used in electric vehicles, offer high energy density but suffer from rapid performance degradation. A research team from KAIST has, for the first time globally, identified the fundamental caus
2025-12-03<(From Left) Ph.D candidate Uichang Jeong, Professor Seungbum Hong> In hydrogen production catalysts, water droplets must detach easily from the surface to prevent blockage by bubbles, allowing for faster hydrogen generation. In semiconductor manufacturing, the quality of the process is determined by how evenly water or liquid spreads on the surface, or how quickly it dries. However, directly observing how such water or liquid spreads and moves on a surface ('wettability') at the nanosc
2025-12-03<(From Left) Professor Yong Woong Jun, Ph.D candidate Tae Ung Jeong, Ph.D candidate Jihun Choi> mRNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the blueprint for functional proteins into the body so that induces therapeutic effects. Recently, its application has expanded to cancer and genetic disease treatments, but mRNA therapeutics have caused serious side effects such as pulmonary embolism, stroke, thromb
2025-12-02